LitAlert ~~ GeneLit.com

    • Volunteer Spotlight – Mike Philbin.
    • [No author given]
    • FORCE. Blog. 2022 Apr 29.
    • Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women.
    • Hardy MW, Peshkin BN, Rose E, Ladd MK, Binion S, Tynan M, McBride CM, Grinzaid KA, Schwartz MD.
    • J Community Genet. 2022 Apr 29. doi: 10.1007/s12687-022-00590-3. Epub ahead of print.
    • Whole-genome and transcriptome analysis of advanced adrenocortical cancer highlights multiple alterations affecting epigenome and DNA repair pathways.
    • Lavoie JM, Csizmok V, Williamson LM, Culibrk L, Wang G, Marra MA, Laskin J, Jones SJM, Renouf DJ, Kollmannsberger CK.
    • Cold Spring Harb Mol Case Stud. 2022 Apr 28;8(3):a006148. doi: 10.1101/mcs.a006148.
    • A pragmatic implementation research study for In Our DNA SC: a protocol to identify multi-level factors that support the implementation of a population-wide genomic screening initiative in diverse populations.
    • Allen CG, Judge DP, Levin E, Sterba K, Hunt K, Ramos PS, Melvin C, Wager K, Catchpole K, Clinton C, Ford M, McMahon LL, Lenert L.
    • Implement Sci Commun. 2022 Apr 28;3(1):48. doi: 10.1186/s43058-022-00286-2.
    • Utility of germline multi-gene panel testing in patients with endometrial cancer.
    • Karpel HC, Chern JY, Smith J M, Smith A J, Pothuri B.
    • Gynecol Oncol. 2022 Apr 25:S0090-8258(22)00216-5. doi: 10.1016/j.ygyno.2022.04.003. Epub ahead of print.